5-Isobutyl-3-phenyl-2-thioxoimidazolidin-4-one

Catalog No.: 
ACVWCT573
CAS No.: 
4399-40-0
Molecular Formula: 
C13H16N2OS
Molecular Weight: 
248.35
5-Isobutyl-3-phenyl-2-thioxoimidazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$84.00InquiryInquiry
250mg98%$156.00InquiryInquiry
1g98%$612.00InquiryInquiry
5g98%$2999.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Isobutyl-3-phenyl-2-thioxoimidazolidin-4-one
IUPAC Name5-isobutyl-3-phenyl-2-thioxoimidazolidin-4-one
MDL No.MFCD00038432
Molecular FormulaC13H16N2OS
Molecular Weight248.35
SMILESO=C(C(CC(C)C)N1)N(C2=CC=CC=C2)C1=S
InChI KeyFMVWVPAXPVSWER-UHFFFAOYSA-N
Synonym5-Isobutyl-3-phenyl-2-thiohydantoin | SR-01000516011-1 | AKOS000637308 | SR-01000516011 | 5-(2-Methylpropyl)-3-phenyl-2-thioxoimidazolidin-4-one | AKOS022012875 | NSC-96424 | E78944 | FMVWVPAXPVSWER-UHFFFAOYSA-N | FT-0635272 | PTH-DL-Leucine | NSC96424 |
CAS No.4399-40-0
PubChem CID3034585

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVWCT573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVWCT573 route product structure diagram
    ACVWCT5734399-40-0
Inquiry

2. ACVWCT573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVWCT573 route product structure diagram
    ACVWCT5734399-40-0
Inquiry

3. ACVWCT573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVWCT573 route product structure diagram
    ACVWCT5734399-40-0
Inquiry

Comments (0)